Fundraising Fox
MetGen
Founded 2008 · 20 employees on LinkedIn · 3 known investors
Find your way into MetGen
Sign up to see every warm intro you have to MetGen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the MetGen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
MetGen develops industrial enzymes for bio-based chemical and material production from biomass and wood feedstocks. The company provides enzyme solutions to biotechnology and chemical manufacturing companies seeking greener alternatives to petroleum-based production processes.
Investors · 3
Emerald Technology Ventures Aglisted by Emerald Technology Ventures AgZurich · $540K – $5.4M
How we know: Emerald Technology Ventures Ag's portfolio page · open dataset · 5k.vc investor directory · Not right? Tell us
Related companies · 4
AmgenAmgen is an independent biotechnology company that uses science and technology, including machine learning and human genetic data, to research and develop treatments for serious diseases such as cancer, heart disease, asthma, and osteoporosis. Its Danish operation, Amgen Danmark, focuses on improving health outcomes for patients and their families in Denmark.
Biogen IdecBiogen is a biotechnology company founded in 1978 that focuses on breakthroughs in biology. The company serves patients through research and development in the life sciences industry.
PepGenPepGen is a clinical-stage biotech company developing oligonucleotide therapies for neuromuscular and neurological diseases using its Enhanced Delivery Oligonucleotide (EDO) platform to improve tissue penetration and uptake in muscle tissues.
MemgenMemgen develops viral, cell-based, and vaccine adjuvant immunotherapies built on its proprietary CD40 ligand technology for treating cancer. Its lead candidate, MEM-288, combines the CD40 ligand with interferon beta and is in phase 1 clinical trials for advanced non-small cell lung cancer.
Companies working in the same space as MetGen.
Frequently asked questions
- What does MetGen do?
- MetGen develops industrial enzymes for bio-based chemical and material production from biomass and wood feedstocks. The company provides enzyme solutions to biotechnology and chemical manufacturing companies seeking greener alternatives to petroleum-based production processes.
- Who are MetGen's investors?
- MetGen's investors include Emerald Technology Ventures Ag, Innovestor Ventures, Tesi (Finnish Industry Investment Ltd).